Yuanji Pan

944 citations
19 papers · 613 indexed · h-index 12
Topics
Cervical Cancer and HPV Research (13 papers)Hepatitis B Virus Studies (9 papers)Immunotherapy and Immune Responses (6 papers)

In The Last Decade

Yuanji Pan

19 papers receiving 601 citations

Peers

Yuanji Pan
Comparison fields: 5 of 57
  • Epidemiology 470
  • Immunology 176
  • Surgery 127
  • Molecular Biology 76
  • Microbiology 54
Replace Helena Faust with:
Helena Faust Sweden
Camilla Lagheden Sweden
Yevgeniy Y. Studentsov United States
RICHARD J. JEWERS United Kingdom
Diego Guillén United States
B Nonnenmacher Brazil
Angélica Teyssie Argentina
Silvaneide Ferreira Brazil
P. Londesborough United Kingdom
Woei Ling Peh United States
Yuanji Pan relative to Helena Faust Sweden Helena Faust's profile →
Citations per field
00.5×1.5×1.8×
Helena Faust · 1×
Citations per year

Countries citing papers authored by Yuanji Pan

Since Specialization
Citations

This map shows the geographic impact of Yuanji Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanji Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanji Pan more than expected).

Fields of papers citing papers by Yuanji Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanji Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanji Pan. The network helps show where Yuanji Pan may publish in the future.

Co-authorship network of co-authors of Yuanji Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanji Pan. A scholar is included among the top collaborators of Yuanji Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanji Pan. Yuanji Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 7
2 1
3
Establishment and validation of competitive ELISA for detecting blocking activity of monoclonal antibody against SARS-CoV-2 RBD
1
4 13
5 11
6 12
7 10
8 57
9 27
10 11
11 23
12 50
13 159
14 13
15 43
16 36
17 1
18 113
19 25

About Yuanji Pan

Yuanji Pan is a scholar working on Otorhinolaryngology, Immunology and Epidemiology, having authored 19 papers that have together received 613 indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (13 papers), Hepatitis B Virus Studies (9 papers) and Immunotherapy and Immune Responses (6 papers). The work is most often cited by research in Epidemiology (470 citations), Otorhinolaryngology (40 citations) and Microbiology (54 citations). Yuanji Pan has collaborated with scholars based in United States, Costa Rica and Mexico. Frequent co-authors include Lígia A. Pinto, Troy J. Kemp, Allan Hildesheim, Carolina Porras, Mahboobeh Safaeian, Douglas R. Lowy, Rolando Herrero, John T. Schiller, Anna R. Giuliano and Leen‐Jan van Doorn. Their work appears in journals such as Blood, The Journal of Infectious Diseases and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026